Case cluster of RT-PCR COVID-19 positive patients with an unexpected benign clinical course with vitamin D, melatonin, vitamin C, and Viscum album

Mark Hancock, Petra Ketterl, Xavier Vinas, Paul G. Werthmann
Article-ID: DMS-21733-EN

  • Login
  • Get Access
  • Export Citation

Background: The SARS-CoV-2 global pandemic has been noted to have a differential effect on those exposed depending on risk factors such as age, diabetes, cardiovascular disease and cancer.

Case presentation: We report a case series of 12 confirmed positive patients and 12 presumptive positive patients all of whom had either an entirely asymptomatic or relatively mild clinical course. 2 patients had active cancer, 3 patients were cancer survivors, 1 patient without cancer was 74 years old. All patients were treated early in their disease course with vitamin D loading (50,000 IU daily for 3 days), 60 to 240 mg melatonin, and 2000 mg oral vitamin C. The 6 high risk patients and one 59 year old patient were treated with at least 2 intravenous doses of vitamin C. The 2 patients with active cancer received 75 grams of vitamin C (one daily, the other every other day). All of the high risk patients had a nearly asymptomatic clinical course and were tested after 10 days and all had a RT PCR for COVID-19 that was negative. The 17 remaining patients also had a relatively benign course though 4 patients (2 in their 20s, 2 in their 50s) received this treatment course later in the course of their illness. These were notably the only patients who had more than a mild sore throat or low grade fever.

Conclusion: We report these unexpectedly positive clinical outcomes of COVID-19 patients including patients with different risk factors, under supplemental vitamin C and D and melatonin. These supplements have a favorable safety profile and are already being suggested as potentially disease altering therapies in the COVID-19 pandemic.

1 Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases 2020;20(5):533–534. DOI: [Crossref]

2 Kakodkar P, Kaka N, Baig MN. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus 2020;12(4):e7560. DOI: [Crossref]

3 Jin X, Lian JS, Hu JH, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020;69(6):1002–1009. DOI: [Crossref]

4 Mahase E. Covid-19: Death rate is 0.66% and increases with age, study estimates. BMJ 2020;369. DOI: [Crossref]

5 Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China. The European Respiratory Journal 2020;55(5):2000547. DOI: [Crossref]

6 Ganatra S, Hammond SP, Nohria A. The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer. JACC CardioOncology 2020;2(2):350–355. DOI: [Crossref]

7 Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncology 2020;21(3):335–337. DOI: [Crossref]

8 Gasmi A, Noor S, Tippairote T, et al. Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Clinical Immunology 2020;215:108409. DOI: [Crossref]

9 Grant WB, Lahore H, McDonnell, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 2020;12(4):988. DOI: [Crossref]

10 Zhang M, Jativa DF. Vitamin C supplementation in the critically ill. Sage Open Medicine 2018;6. DOI: [Crossref]

11 Carr AC. A new clinical trial to test high-dose vitamin C in patients with COVID-19. Critical Care 2020;24(1):133. DOI: [Crossref]

12 Wu GC, Peng CK, Liao WI, et al. Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production. Respiratory Research 2020;21(1):65. DOI: [Crossref]

13 Zhang R, Wang X, Ni L, et al. COVID-19: Melatonin as a potential adjuvant treatment. Life Sciences 2020;250:117583. DOI: [Crossref]

14 Cardinali D, Escames G, Acuña-Castroviejo D, et al. Melatonin-induced oncostasis, mechanisms and clinical relevance. Journal of Integrated Oncology 2016;S1.

15 Evans M, Bryant S, Huntley A, et al. Cancer patients’ experiences of using mistletoe (Viscum album): a qualitative systematic review and synthesis. Journal of Alternative and Complementary Medicine 2016;22(2):134–144. DOI: [Crossref]

16 Saha C, Das M, Stephen-Victor E, et al. Differential effects of Viscum album preparations on the maturation and activation of human dendritic cells and CD4+ t cell responses. Molecules 2016;21(7):912. DOI: [Crossref]

17 Lavelle EC, Grant G, Pusztai A, et al. Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2. Immunology 2002;107(2):268–274. DOI: [Crossref]

18 Tusenius KJ, Spoek AM, van Hattum J. Exploratory study on the effects of treatment with two mistletoe preparations on chronic hepatitis C. Arzneimittelforschung 2005;55(12):749–753. DOI: [Crossref]

19 Gorter RW, van Wely M, Reif M, et al. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals. Alternative Therapies in Health and Medicine 1999;5(6):37–44.

20 Collins KP, Jackson KM, Gustafson DL. Hydroxychloroquine: a physiologically-based pharmacokinetic model in the context of cancer-related autophagy modulation. Journal of Pharmacology and Experimental Therapeutics 2018;365(3):447–459. DOI: [Crossref]

21 Xu K, Chen Y, Yuan J, et al. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clinical Infectious Diseases 2020;ciaa351. DOI: [Crossref]

22 Office of Dietary Supplements. Vitamin C: Fact Sheet for Health Professionals. 2020. Available at (10.05.2023).

23 Adams KK, Baker WL, Sobieraj DM. Myth busters: dietary supplements and COVID-19. Annals of Pharmacotherapy 2020;54(8). DOI: [Crossref]

24 Anderson G, Reiter RJ. Melatonin: Roles in influenza, Covid- 19, and other viral infections. Reviews in Medical Virology 2020;30(3):e2109. DOI: [Crossref]

25 Oei SL, Thronicke A, Schad F. Mistletoe and immunomodulation: insights and implications for anticancer therapies. Evidence- Based Complementary and Alternative Medicine 2019. DOI: [Crossref]

26 Hegde P, Maddur MS, Friboulet A, et al. Viscum album exerts anti-inflammatory effect by selectively inhibiting cytokine- induced expression of cyclooxygenase-2. PLOS ONE 2011;6(10):e26312. DOI: [Crossref]

27 Steinborn C, Klemd AM, Sanchez-Campillo AS, et al. Viscum album neutralizes tumorinduced immunosuppression in a human in vitro cell model. PLOS ONE 2017;12(7):e0181553. [Crossref]

Merkurstab Newsletter
Latest content with links to all articles.
Free of charge. Without obligation.
Open access to selected articles.
Sign up

J O B   M A R K E T

Facharzt oder WB-Assistenzarzt Innere/Allgemeine Medizin (m/w/d)
More details

Arzt in Weiterbildung (m/w/d)
Innere Medizin/Allgemeinmedizin
More details

Assistenzarzt Oberarzt Integrative Medizin (m/w/d)
More details

Facharzt für Kinder- und Jugendmedizin (m/w/d)
Facharzt für Allgemeine Innere Medizin (m/w/d)

More details